Denemek ALTIN - Özgür
How Digital Transformation Strategy could transform Indonesia's healthcare system for the better
BioSpectrum Asia
|BioSpectrum Asia June 2023
Since the COVID-19 epidemic, the digital healthcare business in Indonesia has rapidly expanded. The country needed to modernise its healthcare system, including digitalisation, in addition to enhancing performance and accessibility. Concerns over Indonesia’s healthcare future led to investments in digital healthcare, and the government is now working to encourage its spread.
-
Indonesia’s healthcare sector plays a crucial role in safeguarding the well-being of its people and communities. However, with a population of over 270 million spread across thousands of islands, ensuring equitable access to healthcare services is a significant challenge.
Indonesia’s healthcare industry needs more healthcare talents. The issue is that there are more medical graduates than available job opportunities in the healthcare sector, even in cities. Hospitals then exploit this supply and demand disparity to hire doctors as cheaply as possible to maximise profits, making this more unattractive for local graduates.
Existing doctors work double-triple shifts in multiple places, which can also result in stress and burnout. Many also choose to fly abroad and find better-paying jobs outside the country, resulting in doctor shortage issues in second and thirdtier regions. This condition has an impact on the fulfilment of health talents to build this country’s health landscape to be on par with other developed countries and neighbouring countries in Southeast Asia (SEA).
According to the Ministry of Health of the Republic of Indonesia (MoH), the country requires over 160,000 doctors. At the same time, one of the healthcare reforms planned by the Minister, Budi Gunadi Sadikin, revolves around healthcare talent, among five others, in the 2020-2024 Digital Transformation Strategy. The strategy aims to transform the healthcare system into a more efficient, effective, patient-centred model.
In strengthening and improving healthcare talent, the MoH has also extensively supported health education through multiple scholarship programmes, which aim to support the equitable distribution of health workers. In the future, the government expects that all Indonesian provinces will have essential health services, such as heart disease treatments, by 2024.
Bu hikaye BioSpectrum Asia dergisinin BioSpectrum Asia June 2023 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
BioSpectrum Asia'den DAHA FAZLA HİKAYE
BioSpectrum Asia
India signs MoU with Pfizer to strengthen healthcare innovation ecosystem
In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, Government of India, has signed a Memorandum of Understanding (MoU) with US-based Pfizer Limited.
1 min
BioSpectrum Asia Oct 2025
BioSpectrum Asia
New Zealand to lead new gene therapy trial for muscular dystrophy
The first clinical trial of a new treatment for a rare form of muscular dystrophy is being led by New Zealand-based University of Auckland's Centre for Brain Research.
1 min
BioSpectrum Asia Oct 2025
BioSpectrum Asia
Scientists in Australia grow living skin in world-first
Australia's University of Queensland (UQ) researchers have been the first in the world to successfully grow fully functioning human skin in a laboratory.
1 min
BioSpectrum Asia Oct 2025
BioSpectrum Asia
India joins Health AI Global Regulatory Network to strengthen oversight of AI in healthcare
HealthAI - The Global Agency for Responsible AI in Health, has welcomed India as a pioneer country joining the HealthAI Global Regulatory Network (GRN), a global network of health regulators dedicated to the safe and effective use of artificial intelligence (AI) in healthcare.
1 min
BioSpectrum Asia Oct 2025
BioSpectrum Asia
TVM Capital Healthcare announces first closing of $150 M Southeast Asia Fund
Singapore-based TVM Capital Healthcare, a global private equity investor and operator specialised in healthcare growth capital across emerging markets, has announced the first closing of its $150 million TVM Healthcare Southeast Asia Fund (SEA Fund).
1 min
BioSpectrum Asia Oct 2025
BioSpectrum Asia
National Yang Ming Chiao Tung University, TSH Biopharm collaborate to foster pharma talent in Taiwan
Taiwan's National Yang Ming Chiao Tung University (NYCU) and TSH Biopharm have signed a five-year industry-academia collaboration Memorandum of Understanding (MOU).
1 min
BioSpectrum Asia Oct 2025
BioSpectrum Asia
Fujifilm Biosciences introduces BalanCD HEK293 Perfusion A Medium
Fujifilm Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the life science market, has announced the commercial launch of BalanCD HEK293 Perfusion A.
1 min
BioSpectrum Asia Oct 2025
BioSpectrum Asia
Korea makes smart patch that can run tests using sweat instead of blood
A research team at Korea Advanced Institute of Science and Technology has developed a smart patch that can precisely observe internal changes through sweat when simply attached to the body.
1 min
BioSpectrum Asia Oct 2025
BioSpectrum Asia
ADB approves $106.9 M to strengthen secondary healthcare services in Sri Lanka
The Asian Development Bank (ADB) has approved a $106.9 million financing package to strengthen Sri Lanka's secondary curative care services, improve communicable disease prevention and control, and enhance the healthcare sector's governance and management capacity.
1 min
BioSpectrum Asia Oct 2025
BioSpectrum Asia
Epigenic Therapeutics raises $60 M to accelerate clinical development of medicines
China-based startup Epigenic Therapeutics, a clinical-stage innovative drug development company, has announced the completion of a $60 million Series B round of financing led by Lapam Capital, with continued participation from existing investors Qiming Venture Partners and OrbiMed, and addition of new investors including IFSC and a renowned investment firm in the industry.
1 min
BioSpectrum Asia Oct 2025
Translate
Change font size
